skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 18,676  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
Material Type:
Article
Add to My Research

Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach

Pharmacological reviews, 2018-04, Vol.70 (2), p.348-383 [Peer Reviewed Journal]

Copyright © 2018 by The Author(s). ;info:eu-repo/semantics/openAccess © 2018 by The Author(s) This is an open access article distributed under the CC BY-NC Attribution 4.0 International license (http://creativecommons.org/licenses/by/4.0/). http://creativecommons.org/licenses/by/4.0/ ;ISSN: 0031-6997 ;EISSN: 1521-0081 ;DOI: 10.1124/pr.117.014753 ;PMID: 29507103

Full text available

2
On the alert for cytokine storm: Immunopathology in COVID‐19
Material Type:
Article
Add to My Research

On the alert for cytokine storm: Immunopathology in COVID‐19

Arthritis & Rheumatology, 2020-07 [Peer Reviewed Journal]

2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://novel-coronavirus.onlinelibrary.wiley.com ;DOI: 10.1002/art.41285

Digital Resources/Online E-Resources

3
Targeting inflammation in atherosclerosis - from experimental insights to the clinic
Material Type:
Article
Add to My Research

Targeting inflammation in atherosclerosis - from experimental insights to the clinic

Nature reviews. Drug discovery, 2021-08, Vol.20 (8), p.589-610 [Peer Reviewed Journal]

2021. Springer Nature Limited. ;COPYRIGHT 2021 Nature Publishing Group ;Springer Nature Limited 2021. ;Springer Nature Limited 2021 ;ISSN: 1474-1776 ;ISSN: 1474-1784 ;EISSN: 1474-1784 ;DOI: 10.1038/s41573-021-00198-1 ;PMID: 33976384

Full text available

4
Can Activation of NRF2 Be a Strategy against COVID-19?
Material Type:
Article
Add to My Research

Can Activation of NRF2 Be a Strategy against COVID-19?

Trends in Pharmacological Sciences, 2020-09 [Peer Reviewed Journal]

2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;DOI: 10.1016/j.tips.2020.07.003

Digital Resources/Online E-Resources

5
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China
Material Type:
Article
Add to My Research

The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China

Clinical Immunology, 2020-05, Vol.214 [Peer Reviewed Journal]

2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;DOI: 10.1016/j.clim.2020.108393

Digital Resources/Online E-Resources

6
Colchicine in Patients with Chronic Coronary Disease
Material Type:
Article
Add to My Research

Colchicine in Patients with Chronic Coronary Disease

The New England journal of medicine, 2020-11, Vol.383 (19), p.1838-1847 [Peer Reviewed Journal]

Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2021372 ;PMID: 32865380

Full text available

7
Inflammation in Heart Failure: JACC State-of-the-Art Review
Material Type:
Article
Add to My Research

Inflammation in Heart Failure: JACC State-of-the-Art Review

Journal of the American College of Cardiology, 2020-03, Vol.75 (11), p.1324-1340 [Peer Reviewed Journal]

Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2020.01.014 ;PMID: 32192660

Full text available

8
Current Mechanistic Concepts in Ischemia and Reperfusion Injury
Material Type:
Article
Add to My Research

Current Mechanistic Concepts in Ischemia and Reperfusion Injury

Cellular physiology and biochemistry, 2018-05, Vol.46 (4), p.1650-1667 [Peer Reviewed Journal]

2018 The Author(s). Published by S. Karger AG, Basel ;2018 The Author(s). Published by S. Karger AG, Basel. ;ISSN: 1015-8987 ;EISSN: 1421-9778 ;DOI: 10.1159/000489241 ;PMID: 29694958

Full text available

9
Inflammation in Schizophrenia: Pathogenetic Aspects and Therapeutic Considerations
Material Type:
Article
Add to My Research

Inflammation in Schizophrenia: Pathogenetic Aspects and Therapeutic Considerations

Schizophrenia bulletin, 2018-08, Vol.44 (5), p.973-982 [Peer Reviewed Journal]

The Author(s) 2018. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com 2018 ;ISSN: 0586-7614 ;EISSN: 1745-1701 ;DOI: 10.1093/schbul/sby024 ;PMID: 29648618

Full text available

10
Resolution of inflammation: a new therapeutic frontier
Material Type:
Article
Add to My Research

Resolution of inflammation: a new therapeutic frontier

Nature reviews. Drug discovery, 2016-08, Vol.15 (8), p.551-567 [Peer Reviewed Journal]

COPYRIGHT 2016 Nature Publishing Group ;Copyright Nature Publishing Group Aug 2016 ;ISSN: 1474-1776 ;EISSN: 1474-1784 ;DOI: 10.1038/nrd.2016.39 ;PMID: 27020098

Full text available

11
Innate immune and inflammatory responses to SARS-CoV-2: Implications for COVID-19
Material Type:
Article
Add to My Research

Innate immune and inflammatory responses to SARS-CoV-2: Implications for COVID-19

Cell host & microbe, 2021-07, Vol.29 (7), p.1052-1062 [Peer Reviewed Journal]

2021 Elsevier Inc. ;Copyright © 2021 Elsevier Inc. All rights reserved. ;2021 Elsevier Inc. 2021 Elsevier Inc. ;ISSN: 1931-3128 ;EISSN: 1934-6069 ;DOI: 10.1016/j.chom.2021.05.004 ;PMID: 34022154

Full text available

12
Severe Covid-19
Material Type:
Article
Add to My Research

Severe Covid-19

New England Journal of Medicine, 2020-12, Vol.383 (25), p.2451-2460 [Peer Reviewed Journal]

Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMcp2009575 ;PMID: 32412710

Digital Resources/Online E-Resources

13
ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children
Material Type:
Article
Add to My Research

ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children

Journal of the European Academy of Dermatology and Venereology, 2020-12, Vol.34 (12), p.2717 [Peer Reviewed Journal]

ISSN: 0926-9959 ;EISSN: 1468-3083 ;DOI: 10.1111/jdv.16892

Digital Resources/Online E-Resources

14
Chronic Heart Failure and Inflammation: What Do We Really Know?
Material Type:
Article
Add to My Research

Chronic Heart Failure and Inflammation: What Do We Really Know?

Circulation research, 2016-06, Vol.119 (1), p.159-176 [Peer Reviewed Journal]

2016 American Heart Association, Inc. ;ISSN: 0009-7330 ;EISSN: 1524-4571 ;DOI: 10.1161/CIRCRESAHA.116.308030 ;PMID: 27340274

Full text available

15
Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial
Material Type:
Article
Add to My Research

Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial

JAMA, 2020-10 [Peer Reviewed Journal]

2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://jamanetwork.com/journals/jama/pages/coronavirus-alert . ;DOI: 10.1001/jama.2020.17021

Digital Resources/Online E-Resources

16
Targeting immunometabolism as an anti-inflammatory strategy
Material Type:
Article
Add to My Research

Targeting immunometabolism as an anti-inflammatory strategy

Cell research, 2020-04, Vol.30 (4), p.300-314 [Peer Reviewed Journal]

The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1001-0602 ;EISSN: 1748-7838 ;DOI: 10.1038/s41422-020-0291-z ;PMID: 32132672

Full text available

17
COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome?
Material Type:
Article
Add to My Research

COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome?

Clinical and Experimental Rheumatology, 2020-03, Vol.38 (2), p.337-342 [Peer Reviewed Journal]

ISSN: 0392-856X ;EISSN: 1593-098X ;DOI: 10.55563/CLINEXPRHEUMATOL/XCDARY ;PMID: 32202240

Full text available

18
Therapeutic developments for Duchenne muscular dystrophy
Material Type:
Article
Add to My Research

Therapeutic developments for Duchenne muscular dystrophy

Nature reviews. Neurology, 2019-07, Vol.15 (7), p.373-386 [Peer Reviewed Journal]

COPYRIGHT 2019 Nature Publishing Group ;Springer Nature Limited 2019. ;ISSN: 1759-4758 ;EISSN: 1759-4766 ;DOI: 10.1038/s41582-019-0203-3 ;PMID: 31147635

Full text available

19
Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial
Material Type:
Article
Add to My Research

Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial

BMJ (Online), 2021-01, Vol.372, p.n84 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. BMJ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2021 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.n84 ;PMID: 33472855

Full text available

20
Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease
Material Type:
Article
Add to My Research

Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease

Circulation research, 2020-04, Vol.126 (9), p.1260-1280 [Peer Reviewed Journal]

2020 American Heart Association, Inc. ;ISSN: 0009-7330 ;EISSN: 1524-4571 ;DOI: 10.1161/CIRCRESAHA.120.315937 ;PMID: 32324502

Full text available

Results 1 - 20 of 18,676  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (17,130)

Refine My Results

Creation Date 

From To
  1. Before 1975  (471)
  2. 1975 To 1986  (709)
  3. 1987 To 1998  (1,981)
  4. 1999 To 2011  (7,899)
  5. After 2011  (7,641)
  6. More options open sub menu

Language 

  1. English  (17,693)
  2. Japanese  (2,600)
  3. French  (320)
  4. German  (309)
  5. Spanish  (262)
  6. Portuguese  (220)
  7. Italian  (51)
  8. Polish  (26)
  9. Swedish  (24)
  10. Norwegian  (20)
  11. Russian  (20)
  12. Turkish  (13)
  13. Korean  (12)
  14. Ukrainian  (9)
  15. Chinese  (8)
  16. Czech  (2)
  17. BokmÃ¥l, Norwegian  (2)
  18. Icelandic  (2)
  19. Dutch  (2)
  20. Croatian  (2)
  21. More options open sub menu

Searching Remote Databases, Please Wait